Europe Wearables in Pharma & Biotech Market (2026-2031)
The Europe Wearables in Pharma & Biotech Market was valued at $274.9 Million in 2026 and projected to reach to $688.4 Million by 2031, representing a compound annual growth rate of 20.2%. Europe's wearables in pharma and biotech market is poised for substantial growth, expanding from USD 274.9 million in 2026 to USD 688.4 million by 2031.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Wearables in Pharma & Biotech Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 20.2%, reflecting Europe's strong adoption of digital health technologies and regulatory support for medical-grade wearables.
- Europe leads in integrating wearable devices into clinical trials, remote patient monitoring, and personalized medicine initiatives across major markets including Germany, France, the United Kingdom, and Switzerland. The European market benefits from advanced healthcare infrastructure, stringent quality standards, and significant investment in digital health innovation.
- Europe's regulatory frameworks, particularly CE marking and GDPR compliance, have established trust in wearable solutions among healthcare providers and patients.
- Between 2026 and 2031, Europe is expected to capture increasing market share as pharmaceutical companies and biotech firms leverage wearables for real-world evidence generation, drug efficacy monitoring, and patient engagement strategies..
Key Market Statistics
- CAGR (2026-2031) 20.2% CAGR
- Market Size, 2026 ~USD 274.9 Million
- Forecast, 2031 ~USD 688.4 Million
- Geography Europe
Europe Wearables in Pharma & Biotech Market Overview
Strong Market Valuation :
Europe's wearables in pharma and biotech market is valued at USD 274.9 million in 2026, demonstrating significant investment and adoption across the region's healthcare ecosystem.
Robust Growth Trajectory :
With a CAGR of 20.2% through 2031, Europe's market is expanding rapidly, driven by digital health innovation and increasing demand for remote patient monitoring solutions.
Regulatory Leadership :
Europe's stringent regulatory framework and support for medical-grade wearables position the region as a leader in quality standards and clinical validation of wearable technologies.
Digital Health Integration :
European healthcare systems are actively integrating wearable devices into clinical workflows, supported by strong government initiatives and healthcare provider adoption.
Europe Wearables in Pharma & Biotech Market Dynamics
- This growth is underpinned by Europe's advanced healthcare infrastructure, regulatory support for medical-grade devices, and increasing adoption of digital health technologies across clinical settings.
- The region's emphasis on data privacy and quality standards enhances market credibility and attracts investment. Key drivers include rising chronic disease prevalence, aging populations, and healthcare systems' shift toward preventive care and remote monitoring.
- European pharmaceutical and biotech companies are increasingly incorporating wearables into clinical trials and patient management programs.
- Continued innovation in sensor technology, coupled with favorable reimbursement policies in major markets, will sustain the 20.2% CAGR through 2031, positioning Europe as a critical hub for wearable medical device development and deployment..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Europe's wearables in pharma & biotech market will grow from USD 274.9M (2026) to USD 688.4M (2031) at a 20.2% CAGR.
- Europe leads in regulatory compliance and digital health infrastructure, driving adoption of medical-grade wearables across clinical and commercial applications.
- Real-world evidence generation and remote patient monitoring are primary growth drivers in Europe's pharmaceutical and biotech wearables sector.
- Europe's stringent quality standards and GDPR framework position the region as a trusted hub for wearable innovation in life sciences.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
Europe Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
EUROPE: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 268 | 320.9 | 386.6 | 467.7 | 568.1 | 692.4 | 846.7 | 1038 | 21.8 |
| HEALTHCARE PROVIDERS & CLINICIANS | 84.7 | 99.6 | 117.9 | 140.2 | 167.4 | 200.4 | 240.8 | 290.1 | 19.7 |
| OTHER END USERS | 50.2 | 58.5 | 68.5 | 80.6 | 95 | 112.2 | 132.8 | 157.4 | 18.1 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 405.8 | 480.8 | 572.9 | 685.7 | 824 | 993.6 | 1202 | 1457.8 | 20.5 |
| TOTAL | 808.7 | 959.9 | 1146 | 1374.2 | 1654.5 | 1998.6 | 2422.4 | 2943.3 | 20.8 |
REST OF EUROPE: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 47.8 | 56 | 66.1 | 78.2 | 92.8 | 110.4 | 131.6 | 157 | 18.9 |
| HEALTHCARE PROVIDERS & CLINICIANS | 12.8 | 14.7 | 17 | 19.8 | 23.1 | 26.9 | 31.5 | 37 | 16.8 |
| OTHER END USERS | 9.9 | 11.3 | 12.9 | 14.8 | 17.1 | 19.7 | 22.8 | 26.3 | 15.3 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 69.6 | 80.8 | 94.2 | 110.3 | 129.4 | 152.3 | 179.5 | 211.9 | 17.6 |
| TOTAL | 140 | 162.8 | 190.3 | 223.1 | 262.4 | 309.3 | 365.4 | 432.2 | 17.8 |
Target Audience
- Pharmaceutical Companies : European and global pharma firms need market intelligence to integrate wearables into drug development, clinical trials, and patient monitoring programs across European markets.
- Biotech Innovators : Biotech startups and established companies require regional market data to validate business models, secure funding, and plan European market entry for wearable solutions.
- Medical Device Manufacturers : Wearable device makers need Europe-specific insights on market size, growth rates, and regulatory requirements to optimize product development and commercialization strategies.
- Healthcare Investors : Venture capital, private equity, and institutional investors need comprehensive European market analysis to identify investment opportunities and assess portfolio company growth potential.
- Healthcare Providers & Systems : European hospitals, clinics, and health systems require market intelligence to evaluate wearable adoption, understand vendor landscapes, and plan digital health infrastructure investments.
Key Companies in the Europe Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 851.3 Million |
| France | USD 672.7 Million |
| UK | USD 527.9 Million |
| Italy | USD 249.4 Million |
| Spain | USD 209.9 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing : Obtain precise market valuations for Europe's wearables sector with country-level breakdowns, enabling targeted investment and expansion strategies across key European markets.
- Growth Forecasting : Access detailed projections through 2031 with 20.2% CAGR insights to inform product development timelines, market entry strategies, and resource allocation decisions.
- Regulatory Intelligence : Understand Europe's unique regulatory landscape for medical-grade wearables, including compliance requirements and approval pathways that differ from other global regions.
- Competitive Landscape : Identify leading European players, emerging innovators, and partnership opportunities within the pharma and biotech wearables ecosystem to inform competitive positioning.
- Clinical Integration Insights : Discover how European healthcare systems are integrating wearables into clinical workflows, clinical trials, and patient management programs for real-world adoption strategies.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in Europe?
Europe's wearables in pharma and biotech market was valued at USD 274.9 million in 2026 and is projected to grow to USD 688.4 million by 2031.
What is the expected growth rate for Europe's wearables in pharma & biotech market?
Europe's market is expected to grow at a compound annual growth rate (CAGR) of 20.2% from 2026 to 2031.
Which European countries are leading in wearables adoption for pharma and biotech?
Major markets in Europe include Germany, France, the United Kingdom, and Switzerland, which are driving innovation in clinical trials and remote patient monitoring.
What regulatory frameworks support wearables in Europe's pharma and biotech sector?
Europe's CE marking requirements and GDPR compliance standards establish trust and quality assurance for medical-grade wearables in pharmaceutical and biotech applications.
What are the primary applications of wearables in Europe's pharma and biotech market?
Key applications include real-world evidence generation, remote patient monitoring, clinical trial integration, drug efficacy monitoring, and personalized medicine initiatives.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report